36
Views
10
CrossRef citations to date
0
Altmetric
Research Article

CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA: No Benefit of All-trans-Retinoic Acid Administered in a Short-Course Schedule

, , , , , & show all
Pages 155-162 | Published online: 09 Jul 2009

REFERENCES

  • Tallman MS, Kwaan HC. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood. 1992;79:543–553.
  • Warrell RP, De The H, Yi-Wang Z, Degos L. Acute promyelocytic leukemia. NEnglJMed. 1993;329:177–189.
  • Fenaux P, Le Deley MC, Castaigne S, et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicenter randomized trial. European APL 91 Group. Blood. 1993;82:3241–3249.
  • Kanamaru A, Takemoto Y Tanimoto M, et al., 8c The Japan Adult Leukemia Study. All-Trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood. 1995;85: 1202–1206.
  • Avvisati G, Lo Coco F, Diverio D, et al. AIDA (all-trans-retinoic acid—idarubicin) in newly diag-nosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Pilot Study. Blood. 1996;88:1390–1398.
  • Tallman MS, Andersen JW, Schiffer CA, et al. All-trans-retinoic acid in acute promyelocytic leukemia. N EnglJ Med. 1997;337:1021–1028.
  • Sackmann-Muriel F, Zubizarreta P, Felice MS, et al. Results of treatment with an intensive induc-tion regimen using idarubicin combination with cytarabine and etoposide in children with acute myeloblastic leukemia. Leukemia Res. 1996;20:973–981.
  • Castaigne S, Lefebre P, Chomienne C, et al. Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia. Blood. 1993;82:3560–3563.
  • Douer D, Preston-Martin, Chang E, et al. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood. 1996;87:308–313.
  • Meng-er H, Yu-chen Y Shu-rong C, Jin-ren C, Jia-Xiang L, Long-jun G. Use of All-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72:567–572.
  • Burnett AK, Goldstone AH, Gray RG, Wheatley, K All-trans-retinoic acid given concurrently with induction chemotherapy improves the outcome of APL: results of the UK MRC ATRA trial. Blood. 1997;90 (suppl 1):330a (abstract 1474).
  • Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP. The "retinoic acid syndrome" in acute promyelocytic leukemia. Ann Int Med. 1992;117:292–296.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.